Evogene Evogene
Toggle navigation
  • Company
  • Technology
  • AI Tech-Engines
  • Subsidiaries
  • News & Events
  • Investors
  • Careers
  • Contact

Investor Relations

Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company targeting to revolutionize life-science product development.

INVESTOR RELATIONS CONTACT

 

Rachel Pomerantz Gerber

Head of Investor Relations at Evogene

rachel.pomerantz@evogene.com

+972-8-9311901

 

Upcoming events

All events

INVESTOR EMAIL ALERTS

Sign Up for Investor Relations Email Alerts
    • Stock Quote Stock Quote
    • Financial Reports Financial Reports
    • Sec Filings Sec Filings
    • Press Releases Press Releases
    • Presentations and Webcasts Presentations and Webcasts
    • Analyst Coverage Analyst Coverage
    • Events Events
    • Corporate governance
    Evogene
    • Technology
    • AI Tech-Engines
      • MicroBoost AI
      • ChemPass AI
      • GeneRator AI
    • Press
      • Press releases
      • In the media
      • Webcast
    • Investor Relations
    • About Evogene

    Contact us

    Offices
    13 Gad Feinstein st.,
    Park Rehovot,
    Rehovot, Israel

    Mailing Address
    P.O. Box 4173
    Ness Ziona 7414003,
    Israel

    Tel: 972-8-9311900
    Fax: 972-8-9466724
    E-mail: info@evogene.com

    Facebook icon Linkedin icon

    Privacy Policy
    Terms of Use
    Accessibility Statement

    Copyright © 2023 Evogene Ltd.
    All Rights Reserved.



    CONTACT US

      INVESTOR EMAIL ALERTS

      Sign Up for Investor Relations Email Alerts






        Designed and built by Studio Praktik